tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Revenue

Compare
338 Followers

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 211.25M in the quarter ending Mar 31, 2025, with 6844.31%. This bring the company's revenue in the last twelve months to 214.71M, Decreased 5948.25%. In the fiscal year ending Dec 31, 2024, Keros Therapeutics had annual revenue of 3.55M with 2250.99% growth.
Revenue (ttm)
214.71M
Revenue Growth
91657.69%
P/S Ratio
172.07
Revenue/Employee
$21,779
Employees
163
Market Cap
$610.86M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.55M3.40M+2,250.99%
Dec 31, 2023
151.00K+∞%
Dec 31, 2022
0.00-20.10M-100.00%
Dec 31, 2021
20.10M+∞%
Dec 31, 2020
0.00-10.00M-100.00%
Dec 31, 2019
10.00M0.000.00%
Dec 31, 2018
10.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis